Carrie Cartwright

1.2k total citations
24 papers, 857 citations indexed

About

Carrie Cartwright is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Carrie Cartwright has authored 24 papers receiving a total of 857 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Carrie Cartwright's work include Inflammatory mediators and NSAID effects (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer, Lipids, and Metabolism (4 papers). Carrie Cartwright is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer, Lipids, and Metabolism (4 papers). Carrie Cartwright collaborates with scholars based in United States, China and Spain. Carrie Cartwright's co-authors include Peiying Yang, Robert A. Newman, Diana Chan, David G. Menter, Edward Felix, Apostolia M. Tsimberidou, Susan M. Fischer, Yasuko Kondo, Tomohisa Yokoyama and Mary Johansen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Agricultural and Food Chemistry.

In The Last Decade

Carrie Cartwright

24 papers receiving 835 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carrie Cartwright United States	15	444	244	194	109	93	24	857
Paola Avena Italy	20	490 1.1×	323 1.3×	200 1.0×	78 0.7×	60 0.6×	33	1.2k
Maria Grazia Refolo Italy	18	459 1.0×	246 1.0×	223 1.1×	119 1.1×	90 1.0×	30	992
Debra L. Bemis United States	13	557 1.3×	165 0.7×	189 1.0×	180 1.7×	51 0.5×	21	1.0k
Azhar Ali Singapore	16	635 1.4×	383 1.6×	131 0.7×	107 1.0×	30 0.3×	33	1.2k
Bonan Chen China	18	529 1.2×	179 0.7×	151 0.8×	146 1.3×	61 0.7×	43	960
Song‐Hee Han South Korea	19	404 0.9×	108 0.4×	322 1.7×	100 0.9×	33 0.4×	78	965
Michael Carducci United States	13	436 1.0×	126 0.5×	149 0.8×	85 0.8×	52 0.6×	24	707
Satya S. Pathi United States	15	726 1.6×	356 1.5×	151 0.8×	109 1.0×	38 0.4×	21	981
Sumit J. Shah United States	15	448 1.0×	139 0.6×	130 0.7×	49 0.4×	125 1.3×	23	872
Rit Vatsyayan United States	22	634 1.4×	111 0.5×	178 0.9×	81 0.7×	31 0.3×	33	1.1k

Countries citing papers authored by Carrie Cartwright

Since Specialization

Citations

This map shows the geographic impact of Carrie Cartwright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carrie Cartwright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carrie Cartwright more than expected).

Fields of papers citing papers by Carrie Cartwright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carrie Cartwright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carrie Cartwright. The network helps show where Carrie Cartwright may publish in the future.

Co-authorship network of co-authors of Carrie Cartwright

This figure shows the co-authorship network connecting the top 25 collaborators of Carrie Cartwright. A scholar is included among the top collaborators of Carrie Cartwright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carrie Cartwright. Carrie Cartwright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tsimberidou, Apostolia M., David Vining, Sukeshi Patel Arora, et al.. (2025). Phase I Trial of TTI-101, a First-in-Class Oral Inhibitor of STAT3, in Patients with Advanced Solid Tumors. Clinical Cancer Research. 31(6). 965–974. 15 indexed citations

Tsimberidou, Apostolia M., David Vining, Sukeshi Patel Arora, et al.. (2023). Phase 1 trial evaluating TTI-101, a first-in-class, orally bioavailable, small molecule, inhibitor of STAT3, in patients with advanced solid tumors.. Journal of Clinical Oncology. 41(16_suppl). 3018–3018. 12 indexed citations

Tsimberidou, Apostolia M., Philip Beer, Carrie Cartwright, et al.. (2021). Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors. Clinical Cancer Research. 27(13). 3584–3594. 46 indexed citations

Tsimberidou, Apostolia M., David S. Hong, Jennifer J. Wheler, et al.. (2019). Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine. Journal of Hematology & Oncology. 12(1). 145–145. 46 indexed citations

Michaels, Helen J., et al.. (2019). Relationships Among Population Size, Environmental Factors, and Reproduction in Lupinus perennis (Fabaceae). The American Midland Naturalist. 182(2). 160–160. 2 indexed citations

Tsimberidou, Apostolia M., David S. Hong, Jennifer J. Wheler, et al.. (2018). Precision medicine: Clinical outcomes including long-term survival according to the pathway targeted and treatment period–The IMPACT study.. Journal of Clinical Oncology. 36(18_suppl). LBA2553–LBA2553. 12 indexed citations

Tsimberidou, Apostolia M., David S. Hong, Carrie Cartwright, et al.. (2017). Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): An MD Anderson precision medicine study.. Journal of Clinical Oncology. 35(15_suppl). 2513–2513. 12 indexed citations

Tsimberidou, Apostolia M., David S. Hong, Yang Ye, et al.. (2017). Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): An MD Anderson Precision Medicine Study. JCO Precision Oncology. 2017(1). 1–18. 90 indexed citations

Efuet, Ekem T., et al.. (2015). Huachansu mediates cell death in non-Hodgkin’s lymphoma by induction of caspase-3 and inhibition of MAP kinase. International Journal of Oncology. 47(2). 592–600. 12 indexed citations

10.

Pan, Yong, Lin Tan, Carrie Cartwright, et al.. (2014). PBI-05204, a supercritical CO2 extract of Nerium oleander, inhibits growth of human pancreatic cancer via targeting the PI3K/mTOR pathway. Investigational New Drugs. 33(2). 271–279. 36 indexed citations

11.

Xiao-ping, Ding, et al.. (2014). Abstract 3206: Mistletoe extract inhibits the proliferation of human hepatocellular carcinoma cells by induction of apoptosis and downregulation of c-MYC. Cancer Research. 74(19_Supplement). 3206–3206. 1 indexed citations

12.

Yang, Peiying, Carrie Cartwright, Diana Chan, et al.. (2013). Anticancer activity of fish oils against human lung cancer is associated with changes in formation of PGE₂ and PGE₃ and alteration of Akt phosphorylation. Molecular Carcinogenesis. 53(7). 566–577. 52 indexed citations

13.

Yang, Peiying, Carrie Cartwright, Jin Li, et al.. (2012). Arachidonic acid metabolism in human prostate cancer. International Journal of Oncology. 41(4). 1495–1503. 54 indexed citations

14.

Yang, Peiying, David G. Menter, Carrie Cartwright, et al.. (2009). Oleandrin-mediated inhibition of human tumor cell proliferation: Importance of Na,K-ATPase α subunits as drug targets. Molecular Cancer Therapeutics. 8(8). 2319–2328. 70 indexed citations

15.

Yang, Peiying, Zheng Sun, Diana Chan, et al.. (2008). Zyflamend® reduces LTB 4 formation and prevents oral carcinogenesis in a 7,12-dimethylbenz[α]anthracene (DMBA)-induced hamster cheek pouch model. Carcinogenesis. 29(11). 2182–2189. 25 indexed citations

16.

Yang, Peiying, et al.. (2007). Zyflamend^®-mediated inhibition of human prostate cancer PC3 cell proliferation: Effects on 12-LOX and Rb protein phosphorylation. Cancer Biology & Therapy. 6(2). 228–236. 23 indexed citations

17.

Yang, Peiying, Diana Chan, Carrie Cartwright, et al.. (2006). The dual PPARα/γ ligand TZD18 inhibits cell growth and induces apoptosis in human Bcr-Abl positive CML cell lines >in vitro. Cancer Research. 66. 906–906. 1 indexed citations

18.

Yang, Peiying, et al.. (2006). Zyflamend®-mediated inhibition of human prostate cancer PC3 cell proliferation: Effects on 12-LOX and Rb protein phosphorylation .. Cancer Epidemiology and Prevention Biomarkers. 15. 1 indexed citations

19.

Newman, Robert A., Peiying Yang, Walter N. Hittelman, et al.. (2006). Oleandrin-mediated oxidative stress in human melanoma cells.. PubMed. 5(3). 167–81. 72 indexed citations

20.

Yang, Peiying, Diana Chan, Edward Felix, et al.. (2004). Formation and antiproliferative effect of prostaglandin E3 from eicosapentaenoic acid in human lung cancer cells. Journal of Lipid Research. 45(6). 1030–1039. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact